Delivra Health Brands Inc

Delivra Health Brands Inc's next confirmed earnings release is scheduled for October 23, 2026.

As of March 31, 2026, Delivra Health Brands Inc has 31.26M shares outstanding.

As of March 31, 2026, Delivra Health Brands Inc maintains a current ratio of 3.29, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 79.33, indicating elevated leverage, while an interest coverage ratio of -4.96 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Delivra Health Brands Inc posted a negative return on equity (ROE) of -53.83, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -25.05, reflecting losses generated across the asset base. Inventory turnover of 3.11 indicates how many times Delivra Health Brands Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

These figures are as of the close on October 22, 2026.

Over the twelve months ended March 31, 2026, Delivra Health Brands Inc generated 6.21M in revenue and converted that into -1.21M in net income, yielding earnings per share of -0.04. EBITDA reached -857,834.22, while operating income came in at -1.08M.

As of March 31, 2026, Delivra Health Brands Inc holds 1.64M in cash and equivalents against 1.45M in total debt, resulting in a net debt position of -189,731.28. Total book value stands at 1.83M, with working capital of 3.08M providing operational flexibility.

Delivra Health Brands Inc produced -944,301.92 in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Delivra Health Brands Inc posted a gross margin of 43.44, reflecting its pricing power and cost economics. The operating margin of -17.35 and net profit margin of -19.56 provide insight into operational efficiency.

Delivra Health Brands Inc's most recent stock split took place on February 21, 2025 with a 10:1 split ratio.